Mirae Asset Global Investments Co., Ltd. Krystal Biotech, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 958 shares of KRYS stock, worth $155,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
958
Previous 1,039
7.8%
Holding current value
$155,109
Previous $188,000
20.21%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding KRYS
# of Institutions
304Shares Held
24.4MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$639 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$466 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$426 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$207 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$142 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.16B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...